Outrage as cystic fibrosis drug firm posts big profit The Observer, February 10, 2019

Main|Search|PHGKB






Last Posted: Feb 10, 2019

---

• Outrage as cystic fibrosis drug firm posts big profit 
  The Observer, February 10, 2019
• ‘We’re still waiting’: As cystic fibrosis drugs deliver new hope, not everyone is being swept up by scientific progress
  A Joseph, Stat News, February 4, 2019
• Children with cystic fibrosis are infected with multiple subpopulations of Mycobacterium abscessus with different antimicrobial resistance profiles.
  Shaw Liam P et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019 Jan
• Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement.
  Wu Ann Chen et al. American journal of respiratory and critical care medicine 2018 Dec 198(12) e116-e136
• Comparison of two sweat test systems for the diagnosis of cystic fibrosis in newborns.
  Rueegg Corina S et al. Pediatric pulmonology 2019 Jan
• Cystic fibrosis: What's new in South Africa in 2019.
  Zampoli On Behalf Of The Msac M et al. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2018 Dec 109(1) 16-19
• Human Molecular Genetics Has Not Yet Contributed to Measurable Public Health Advances.
  Paneth Nigel et al. Perspectives in biology and medicine 2018 61(4) 537-549
• Acceptability of Electronic Visits for Return of Research Results in the Mayo Clinic Biobank.
  Olson Janet E et al. Mayo Clinic proceedings. Innovations, quality & outcomes 2018 Dec 2(4) 352-358
• The Incidence of Cystic Fibrosis in Central Anatolia Region of Turkey in 2015 and 2016
  Hangül Melih et al. Balkan medical journal 2018 Dec
• Triplet CFTR modulators: future prospects for treatment of cystic fibrosis.
  Chaudary Nauman et al. Therapeutics and clinical risk management 2018 142375-2383

more